{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T07:58:09Z","timestamp":1790323089268,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["F31CA265218"],"award-info":[{"award-number":["F31CA265218"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA232563"],"award-info":[{"award-number":["U01 CA232563"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA232563"],"award-info":[{"award-number":["U01 CA232563"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA232563"],"award-info":[{"award-number":["U01 CA232563"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100006315","name":"CureSearch for Children\u2019s Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019329","name":"Emerson Collective","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019329","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01 GM128096"],"award-info":[{"award-number":["R01 GM128096"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100006315","name":"CureSearch for Children\u2019s Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006315","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identification of cancer sub-types is a pivotal step for developing personalized treatment. Specifically, sub-typing based on changes in RNA splicing has been motivated by several recent studies. We thus develop CHESSBOARD, an unsupervised algorithm tailored for RNA splicing data that captures \u201ctiles\u201d in the data, defined by a subset of unique splicing changes in a subset of patients. CHESSBOARD allows for a flexible number of tiles, accounts for uncertainty of splicing quantification, and is able to model missing values as additional signals. We first apply CHESSBOARD to synthetic data to assess its domain specific modeling advantages, followed by analysis of several leukemia datasets. We show detected tiles are reproducible in independent studies, investigate their possible regulatory drivers and probe their relation to known AML mutations. Finally, we demonstrate the potential clinical utility of CHESSBOARD by supplementing mutation based diagnostic assays with discovered splicing profiles to improve drug response correlation.<\/jats:p>","DOI":"10.1038\/s41467-022-35369-0","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:05:50Z","timestamp":1672848350000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers"],"prefix":"10.1038","volume":"14","author":[{"given":"David","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9945-8123","authenticated-orcid":false,"given":"Mathieu","family":"Quesnel-Vallieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Elzubeir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2739-2206","authenticated-orcid":false,"given":"Andrei","family":"Thomas-Tikhonenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3005-5048","authenticated-orcid":false,"given":"Yoseph","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"35369_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"S-I Lee","year":"2018","unstructured":"Lee, S.-I. et al. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia. Nat. Commun. 9, 1\u201313 (2018).","journal-title":"Nat. Commun."},{"key":"35369_CR2","doi-asserted-by":"publisher","first-page":"172\u2013180.e3","DOI":"10.1016\/j.celrep.2018.03.046","volume":"23","author":"GP Way","year":"2018","unstructured":"Way, G. P. et al. Machine learning detects pan-cancer ras pathway activation in the cancer genome atlas. Cell Rep. 23, 172\u2013180.e3 (2018).","journal-title":"Cell Rep."},{"key":"35369_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-34753-5","volume":"8","author":"C Huang","year":"2018","unstructured":"Huang, C. et al. Machine learning predicts individual cancer patient responses to therapeutic drugs with high accuracy. Sci. Rep. 8, 1\u20138 (2018).","journal-title":"Sci. Rep."},{"key":"35369_CR4","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1093\/bioinformatics\/btp543","volume":"25","author":"R Shen","year":"2009","unstructured":"Shen, R., Olshen, A. B. & Ladanyi, M. Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysis. Bioinformatics 25, 2906\u20132912 (2009).","journal-title":"Bioinformatics"},{"key":"35369_CR5","doi-asserted-by":"publisher","first-page":"540\u2013556.e25","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556.e25 (2017).","journal-title":"Cell"},{"key":"35369_CR6","doi-asserted-by":"publisher","first-page":"e151627","DOI":"10.1172\/JCI151627","volume":"131","author":"PS Choi","year":"2021","unstructured":"Choi, P. S. & Thomas-Tikhonenko, A. RNA-binding proteins of COSMIC importance in cancer. J. Clin. Investig. 131, e151627 (2021).","journal-title":"J. Clin. Investig."},{"key":"35369_CR7","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nrm.2017.130","volume":"19","author":"MW Hentze","year":"2018","unstructured":"Hentze, M. W., Castello, A., Schwarzl, T. & Preiss, T. A brave new world of RNA-binding proteins. Nat. Rev. Mol. Cell Biol. 19, 327\u2013341 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"35369_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41576-020-00302-y","volume":"22","author":"F Gebauer","year":"2021","unstructured":"Gebauer, F., Schwarzl, T., Valc\u00e1rcel, J. & Hentze, M. W. RNA-binding proteins in human genetic disease. Nat. Rev. Genet. 22, 185\u2013198 (2021).","journal-title":"Nat. Rev. Genet."},{"key":"35369_CR9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"35369_CR10","doi-asserted-by":"crossref","unstructured":"Rivera, O. D. et al. Alternative splicing redefines landscape of commonly mutated genes in acute myeloid leukemia. Proc. Natl Acad. Sci. 118, e2014967118 (2021).","DOI":"10.1073\/pnas.2014967118"},{"key":"35369_CR11","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.ccell.2015.04.006","volume":"27","author":"E Kim","year":"2015","unstructured":"Kim, E. et al. SRSF2 mutations contribute to myelodysplasia by mutant-specific effects on exon recognition. Cancer Cell 27, 617\u2013630 (2015).","journal-title":"Cancer Cell"},{"key":"35369_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","volume":"562","author":"JW Tyner","year":"2018","unstructured":"Tyner, J. W. et al. Functional genomic landscape of acute myeloid leukaemia. Nature 562, 526\u2013531 (2018).","journal-title":"Nature"},{"key":"35369_CR13","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1101\/gad.338962.120","volume":"34","author":"S Cherry","year":"2020","unstructured":"Cherry, S. & Lynch, K. W. Alternative splicing and cancer: insights, opportunities, and challenges from an expanding view of the transcriptome. Genes Dev. 34, 1005\u20131016 (2020).","journal-title":"Genes Dev."},{"key":"35369_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li, B. & Dewey, C. N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinform. 12, 1\u201316 (2011).","journal-title":"BMC Bioinform."},{"key":"35369_CR15","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nmeth.4197","volume":"14","author":"R Patro","year":"2017","unstructured":"Patro, R., Duggal, G., Love, M. I., Irizarry, R. A. & Kingsford, C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods 14, 417\u2013419 (2017).","journal-title":"Nat. Methods"},{"key":"35369_CR16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"35369_CR17","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nmeth.1528","volume":"7","author":"Y Katz","year":"2010","unstructured":"Katz, Y., Wang, E. T., Airoldi, E. M. & Burge, C. B. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 7, 1009\u20131015 (2010).","journal-title":"Nat. Methods"},{"key":"35369_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-01967-8","volume":"21","author":"S Tiberi","year":"2020","unstructured":"Tiberi, S. & Robinson, M. D. BANDITS: Bayesian differential splicing accounting for sample-to-sample variability and mapping uncertainty. Genome Biol. 21, 1\u201313 (2020).","journal-title":"Genome Biol."},{"key":"35369_CR19","doi-asserted-by":"publisher","first-page":"e11752","DOI":"10.7554\/eLife.11752","volume":"5","author":"J Vaquero-Garcia","year":"2016","unstructured":"Vaquero-Garcia, J. et al. A new view of transcriptome complexity and regulation through the lens of local splicing variations. elife 5, e11752 (2016).","journal-title":"elife"},{"key":"35369_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-018-1417-1","volume":"19","author":"JL Trincado","year":"2018","unstructured":"Trincado, J. L. et al. SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions. Genome Biol. 19, 1\u201311 (2018).","journal-title":"Genome Biol."},{"key":"35369_CR21","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen, S. et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc. Natl Acad. Sci. 111, E5593\u2013E5601 (2014).","journal-title":"Proc. Natl Acad. Sci."},{"key":"35369_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-9-S1-S4","volume":"9","author":"J Gu","year":"2008","unstructured":"Gu, J. & Liu, J. S. Bayesian biclustering of gene expression data. BMC Genom. 9, 1\u201310 (2008).","journal-title":"BMC Genom."},{"key":"35369_CR23","unstructured":"Meeds, E. & Roweis, S. Nonparametric bayesian biclustering. Tech. Rep. Citeseer (2007)."},{"key":"35369_CR24","unstructured":"Givoni, I., Cheung, V. & Frey, B. J. Matrix tile analysis. arXiv preprint arXiv:1206.6833 (2012)."},{"key":"35369_CR25","doi-asserted-by":"publisher","first-page":"e1004791","DOI":"10.1371\/journal.pcbi.1004791","volume":"12","author":"C Gao","year":"2016","unstructured":"Gao, C., McDowell, I. C., Zhao, S., Brown, C. D. & Engelhardt, B. E. Context specific and differential gene co-expression networks via Bayesian biclustering. PLoS Comput. Biol. 12, e1004791 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"35369_CR26","first-page":"759","volume":"8","author":"Y Xu","year":"2013","unstructured":"Xu, Y. et al. Nonparametric bayesian bi-clustering for next generation sequencing count data. Bayesian Analy. (Online) 8, 759 (2013).","journal-title":"Bayesian Analy. (Online)"},{"key":"35369_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/biomet\/63.3.581","volume":"63","author":"DB Rubin","year":"1976","unstructured":"Rubin, D. B. Inference and missing data. Biometrika 63, 581\u2013592 (1976).","journal-title":"Biometrika"},{"key":"35369_CR28","doi-asserted-by":"publisher","unstructured":"Dhillon, I. S. Co-clustering documents and words using bipartite spectral graph partitioning. In Proceedings of the seventh ACM SIGKDD international conference on Knowledge discovery and data mining, 269\u2013274 https:\/\/doi.org\/10.1145\/502512.502550 (2001).","DOI":"10.1145\/502512.502550"},{"key":"35369_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23608-9","volume":"12","author":"B Slaff","year":"2021","unstructured":"Slaff, B. et al. MOCCASIN: A method for correcting for known and unknown confounders in RNA splicing analysis. Nat. Commun. 12, 1\u20139 (2021).","journal-title":"Nat. Commun."},{"key":"35369_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-016-0315-9","volume":"9","author":"R de Necochea-Campion","year":"2016","unstructured":"de Necochea-Campion, R., Shouse, G. P., Zhou, Q., Mirshahidi, S. & Chen, C.-S. Aberrant splicing and drug resistance in AML. J. Hematol. Oncol. 9, 1\u20139 (2016).","journal-title":"J. Hematol. Oncol."},{"key":"35369_CR31","doi-asserted-by":"crossref","unstructured":"Anande, G. et al. RNA Splicing Alterations Induce a Cellular Stress Response Associated with Poor Prognosis in Acute Myeloid LeukemiaRNA Splicing Alterations in AML. Clin Cancer Res. 26, 3597\u20133607 (2020).","DOI":"10.1158\/1078-0432.CCR-20-0184"},{"key":"35369_CR32","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1158\/1541-7786.MCR-14-0131","volume":"12","author":"S Das","year":"2014","unstructured":"Das, S. & Krainer, A. R. Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol. Cancer Res. 12, 1195\u20131204 (2014).","journal-title":"Mol. Cancer Res."},{"key":"35369_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/nsmb.2207","volume":"19","author":"O Anczuk\u00f3w","year":"2012","unstructured":"Anczuk\u00f3w, O. et al. The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol. 19, 220\u2013228 (2012).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"35369_CR34","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1194\/jlr.C600003-JLR200","volume":"47","author":"A Massiello","year":"2006","unstructured":"Massiello, A. & Chalfant, C. E. SRp30a (ASF\/SF2) regulates the alternative splicing of caspase-9 pre-mRNA and is required for ceramide-responsiveness. J. Lipid Res. 47, 892\u2013897 (2006).","journal-title":"J. Lipid Res."},{"key":"35369_CR35","doi-asserted-by":"publisher","first-page":"6373","DOI":"10.1038\/sj.onc.1209889","volume":"25","author":"JH Reiling","year":"2006","unstructured":"Reiling, J. H. & Sabatini, D. M. Stress and mTORture signaling. Oncogene 25, 6373\u20136383 (2006).","journal-title":"Oncogene"},{"key":"35369_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1007\/s00277-014-2072-6","volume":"93","author":"M Port","year":"2014","unstructured":"Port, M. et al. Prognostic significance of FLT3 internal tandem duplication, nucleophosmin 1, and CEBPA gene mutations for acute myeloid leukemia patients with normal karyotype and younger than 60 years: a systematic review and meta-analysis. Ann. Hematol. 93, 1279\u20131286 (2014).","journal-title":"Ann. Hematol."},{"key":"35369_CR37","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"CGAR Network","year":"2013","unstructured":"Network, C. G. A. R. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl J. Med."},{"key":"35369_CR38","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.3390\/cancers13163929","volume":"13","author":"A Wojtuszkiewicz","year":"2021","unstructured":"Wojtuszkiewicz, A. et al. Maturation State-Specific Alternative Splicing in FLT3-ITD and NPM1 Mutated AML. Cancers 13, 3929 (2021).","journal-title":"Cancers"},{"key":"35369_CR39","doi-asserted-by":"publisher","first-page":"3254","DOI":"10.1182\/bloodadvances.2021004556","volume":"5","author":"I van der Werf","year":"2021","unstructured":"van der Werf, I. et al. Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification. Blood Adv. 5, 3254\u20133265 (2021).","journal-title":"Blood Adv."},{"key":"35369_CR40","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/leu.2008.26","volume":"22","author":"LS Steelman","year":"2008","unstructured":"Steelman, L. S. et al. Contributions of the Raf\/MEK\/ERK, PI3K\/PTEN\/Akt\/mTOR and Jak\/STAT pathways to leukemia. Leukemia 22, 686\u2013707 (2008).","journal-title":"Leukemia"},{"key":"35369_CR41","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat. Med. 24, 103\u2013112 (2018).","journal-title":"Nat. Med."},{"key":"35369_CR42","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature25480","volume":"555","author":"SN Gr\u00f6bner","year":"2018","unstructured":"Gr\u00f6bner, S. N. et al. The landscape of genomic alterations across childhood cancers. Nature 555, 321\u2013327 (2018).","journal-title":"Nature"},{"key":"35369_CR43","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature25795","volume":"555","author":"X Ma","year":"2018","unstructured":"Ma, X. et al. Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours. Nature 555, 371\u2013376 (2018).","journal-title":"Nature"},{"key":"35369_CR44","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/leu.2012.155","volume":"27","author":"S Krentz","year":"2013","unstructured":"Krentz, S. et al. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Leukemia 27, 295\u2013304 (2013).","journal-title":"Leukemia"},{"key":"35369_CR45","first-page":"11357","volume":"46","author":"KL Black","year":"2018","unstructured":"Black, K. L. et al. Aberrant splicing in B-cell acute lymphoblastic leukemia. Nucleic Aacids Res. 46, 11357\u201311369 (2018).","journal-title":"Nucleic Aacids Res."},{"key":"35369_CR46","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1158\/2159-8290.CD-15-1020","volume":"5","author":"E Sotillo","year":"2015","unstructured":"Sotillo, E. et al. Convergence of acquired mutations and alternative splicing of CD19 enables resistance to CART-19 immunotherapy. Cancer Discov. 5, 1282\u20131295 (2015).","journal-title":"Cancer Discov."},{"key":"35369_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-015-0805-z","volume":"16","author":"E Pierson","year":"2015","unstructured":"Pierson, E. & Yau, C. ZIFA: Dimensionality reduction for zero-inflated single-cell gene expression analysis. Genome Biol. 16, 1\u201310 (2015).","journal-title":"Genome Biol."},{"key":"35369_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-02015-1","volume":"21","author":"R Argelaguet","year":"2020","unstructured":"Argelaguet, R. et al. MOFA+: a statistical framework for comprehensive integration of multi-modal single-cell data. Genome Biol. 21, 1\u201317 (2020).","journal-title":"Genome Biol."},{"key":"35369_CR49","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41568-018-0074-8","volume":"18","author":"D Mossmann","year":"2018","unstructured":"Mossmann, D., Park, S. & Hall, M. N. mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat. Rev. Cancer 18, 744\u2013757 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"35369_CR50","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.drup.2008.03.001","volume":"11","author":"B-H Jiang","year":"2008","unstructured":"Jiang, B.-H. & Liu, L.-Z. Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resist. Updates 11, 63\u201376 (2008).","journal-title":"Drug Resist. Updates"},{"key":"35369_CR51","doi-asserted-by":"publisher","first-page":"5119","DOI":"10.1038\/onc.2016.41","volume":"35","author":"O Lindblad","year":"2016","unstructured":"Lindblad, O. et al. Aberrant activation of the PI3K\/mTOR pathway promotes resistance to sorafenib in AML. Oncogene 35, 5119\u20135131 (2016).","journal-title":"Oncogene"},{"key":"35369_CR52","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1089\/cbr.2017.2187","volume":"32","author":"H Yi","year":"2017","unstructured":"Yi, H. et al. Inhibition of the AKT\/mTOR pathway augments the anticancer effects of sorafenib in thyroid cancer. Cancer Biother. Radiopharmaceut. 32, 176\u2013183 (2017).","journal-title":"Cancer Biother. Radiopharmaceut."},{"key":"35369_CR53","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00280-019-03918-y","volume":"84","author":"MN Kim","year":"2019","unstructured":"Kim, M. N., Lee, S. M., Kim, J. S. & Hwang, S. G. Preclinical efficacy of a novel dual PI3K\/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma. Cancer Chemother. Pharmacol. 84, 809\u2013817 (2019).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"35369_CR54","first-page":"2531","volume":"32","author":"R Gedaly","year":"2012","unstructured":"Gedaly, R. et al. The role of PI3K\/mTOR inhibition in combination with sorafenib in hepatocellular carcinoma treatment. Anticancer Res. 32, 2531\u20132536 (2012).","journal-title":"Anticancer Res."},{"key":"35369_CR55","doi-asserted-by":"crossref","unstructured":"Damnernsawad, A. et al. Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia. Haematologica 107, 77\u201385 (2020).","DOI":"10.3324\/haematol.2020.257964"},{"key":"35369_CR56","unstructured":"Burdziak, C., Azizi, E., Prabhakaran, S. & Pe\u2019er, D. A nonparametric multi-view model for estimating cell type-specific gene regulatory networks. arXiv preprint arXiv:1902.08138 (2019)."},{"key":"35369_CR57","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41586-020-2077-3","volume":"583","author":"EL Van Nostrand","year":"2020","unstructured":"Van Nostrand, E. L. et al. A large-scale binding and functional map of human RNA-binding proteins. Nature 583, 711\u2013719 (2020).","journal-title":"Nature"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35369-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35369-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T18:03:26Z","timestamp":1672855406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-35369-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["35369"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-35369-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"2 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"63"}}